NCT03162172View on ClinicalTrials.gov

Growth Hormone (GH) in Congenital Adrenal Hyperplasia

CompletedOBSERVATIONAL

Enrollment

25

Participants

Timeline

Start Date

September 15, 2015

Primary Completion Date

March 15, 2016

Study Completion Date

March 15, 2016

Conditions

Adrenal Hyperplasia, Congenital

Trial Locations (1)

69500

Hospices Civils de Lyon, Lyon

All Listed Sponsors

lead

Hospices Civils de Lyon

OTHER

NCT03162172 - Growth Hormone (GH) in Congenital Adrenal Hyperplasia | Biotech Hunter | Biotech Hunter